196 related articles for article (PubMed ID: 35273063)
1. Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study.
Runels T; Ragan EJ; Ventura AS; Winter MR; White LF; Horsburgh CR; Samet JH; Saitz R; Jacobson KR
BMJ Open; 2022 Mar; 12(3):e058751. PubMed ID: 35273063
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
3. The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidates.
Foppiano Palacios C; Medvedeva N; Cheung H; Cohen E; Azar MM; Malinis M
Transpl Infect Dis; 2023 Feb; 25(1):e13999. PubMed ID: 36484433
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States.
Holzman SB; Perry A; Saleeb P; Pyan A; Keh C; Salcedo K; Narita M; Ahmed A; Miller TL; Pettit AC; Khurana R; Whipple M; Katz D; Largen A; Krueger A; Shah M;
Clin Infect Dis; 2022 Nov; 75(10):1792-1799. PubMed ID: 35363249
[TBL] [Abstract][Full Text] [Related]
6. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
7. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.
Berrocal-Almanza LC; Harris RJ; Collin SM; Muzyamba MC; Conroy OD; Mirza A; O'Connell AM; Altass L; Anderson SR; Thomas HL; Campbell C; Zenner D; Phin N; Kon OM; Smith EG; Lalvani A
Lancet Public Health; 2022 Apr; 7(4):e305-e315. PubMed ID: 35338849
[TBL] [Abstract][Full Text] [Related]
9. Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening.
Lim RK; Talavlikar R; Chiazor O; Bietz J; Gardiner H; Fisher D
BMC Infect Dis; 2021 Sep; 21(1):936. PubMed ID: 34503458
[TBL] [Abstract][Full Text] [Related]
10. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
[TBL] [Abstract][Full Text] [Related]
11. Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
Wong NS; Chan KCW; Wong BCK; Leung CC; Chan WK; Lin AWC; Lui GCY; Mitchell KM; Lee SS
JAMA Netw Open; 2019 Sep; 2(9):e1910960. PubMed ID: 31490541
[TBL] [Abstract][Full Text] [Related]
12. Determinants of losses in the latent tuberculosis infection cascade of care in Brazil.
Souza AB; Arriaga MB; Amorim G; Araújo-Pereira M; Nogueira BMF; Queiroz ATL; Figueiredo MC; Rocha MS; Benjamin A; Moreira ASR; Oliveira JG; Rolla V; Durovni B; Lapa E Silva JR; Kritski AL; Cavalcante S; Sterling T; Andrade BB; Cordeiro-Santos M;
BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34518204
[TBL] [Abstract][Full Text] [Related]
13. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015-2018: a record linkage study of the care cascade.
Nederby Öhd J; Hergens MP; Luksha Y; Buxbaum C; Shedrawy J; Jonsson J; Bruchfeld J; Lönnroth K
Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 32855227
[TBL] [Abstract][Full Text] [Related]
15. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
[TBL] [Abstract][Full Text] [Related]
16. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
[TBL] [Abstract][Full Text] [Related]
18. Positive rate and risk factors of latent tuberculosis infection among persons living with HIV in Jiangsu Province, China.
Zhang Y; Lu P; Wu K; Zhou H; Yu H; Yuan J; Dong L; Liu Q; Lu W; Yang H; Cao D; Zhu L
Front Cell Infect Microbiol; 2023; 13():1051060. PubMed ID: 36960041
[TBL] [Abstract][Full Text] [Related]
19. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
20. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
